Literature DB >> 16737960

TLR8-mediated NF-kappaB and JNK activation are TAK1-independent and MEKK3-dependent.

Jinzhong Qin1, Jianhong Yao, Grace Cui, Hui Xiao, Tae Whan Kim, Jerzy Fraczek, Paul Wightman, Shintaro Sato, Shizuo Akira, Anne Puel, Jean-Laurent Casanova, Bing Su, Xiaoxia Li.   

Abstract

TLR8-mediated NF-kappaB and IRF7 activation are abolished in human IRAK-deficient 293 cells and IRAK4-deficient fibroblast cells. Both wild-type and kinase-inactive mutants of IRAK and IRAK4, respectively, restored TLR8-mediated NF-kappaB and IRF7 activation in the IRAK- and IRAK4-deficient cells, indicating that the kinase activity of IRAK and IRAK4 is probably redundant for TLR8-mediated signaling. We recently found that TLR8 mediates a unique NF-kappaB activation pathway in human 293 cells and mouse embryonic fibroblasts, accompanied only by IkappaBalpha phosphorylation and not IkappaBalpha degradation, whereas interleukin (IL)-1 stimulation causes both IkappaBalpha phosphorylation and degradation. The intermediate signaling events mediated by IL-1 (including IRAK modifications and degradation and TAK1 activation) were not detected in cells stimulated by TLR8 ligands. TLR8 ligands trigger similar levels of IkappaBalpha phosphorylation and NF-kappaB and JNK activation in TAK1(-/-) mouse embryo fibroblasts (MEFs) as compared with wild-type MEFs, whereas lack of TAK1 results in reduced IL-1-mediated NF-kappaB activation and abolished IL-1-induced JNK activation. The above results indicate that although TLR8-mediated NF-kappaB and JNK activation are IRAK-dependent, they do not require IRAK modification and are TAK1-independent. On the other hand, TLR8-mediated IkappaBalpha phosphorylation, NF-kappaB, and JNK activation are completely abolished in MEKK3(-/-) MEFs, whereas IL-1-mediated signaling was only moderately reduced in these deficient MEFs as compared with wild-type cells. The differences between IL-1R- and TLR8-mediated NF-kappaB activation are also reflected at the level of IkappaB kinase (IKK) complex. TLR8 ligands induced IKKgamma phosphorylation, whereas IKKalpha/beta phosphorylation and IKKgamma ubiquitination that can be induced by IL-1 were not detected in cells treated with TLR8 ligands. We postulate that TLR8-mediated MEKK3-dependent IKKgamma phosphorylation might play an important role in the activation of IKK complex, leading to IkappaBalpha phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16737960     DOI: 10.1074/jbc.M512908200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function.

Authors:  Yanyan Wang; Gonghua Huang; Peter Vogel; Geoffrey Neale; Boris Reizis; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 2.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

3.  MEKK3 is essential for lymphopenia-induced T cell proliferation and survival.

Authors:  Xiaofang Wang; Xing Chang; Valeria Facchinetti; Yuan Zhuang; Bing Su
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

4.  TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway.

Authors:  Ryoko Yoshida; Giichi Takaesu; Hideyuki Yoshida; Fuyuki Okamoto; Tomoko Yoshioka; Yongwon Choi; Shizuo Akira; Taro Kawai; Akihiko Yoshimura; Takashi Kobayashi
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

5.  IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.

Authors:  Yanbao Xiong; Meghan Pennini; Stefanie N Vogel; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2013-05-21       Impact factor: 4.962

6.  TLR8-mediated activation of human monocytes inhibits TL1A expression.

Authors:  Masayuki Saruta; Kathrin S Michelsen; Lisa S Thomas; Qi T Yu; Carol J Landers; Stephan R Targan
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

7.  Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).

Authors:  Dongxu Sun; Michael Novotny; Katarzyna Bulek; Caini Liu; Xiaoxia Li; Thomas Hamilton
Journal:  Nat Immunol       Date:  2011-08-07       Impact factor: 25.606

8.  Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.

Authors:  Laura M Fahey; Adam B Raff; Diane M Da Silva; W Martin Kast
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  Homeostatic interactions between MEKK3 and TAK1 involved in NF-kappaB signaling.

Authors:  Yuwei Di; Shitao Li; Lingyan Wang; Ye Zhang; Martin E Dorf
Journal:  Cell Signal       Date:  2008-01-18       Impact factor: 4.315

10.  Gene expression analysis in children with complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis.

Authors:  Mitsuru Tsuge; Takashi Oka; Nobuko Yamashita; Yukie Saito; Yosuke Fujii; Yoshiharu Nagaoka; Masato Yashiro; Hirokazu Tsukahara; Tsuneo Morishima
Journal:  J Neurovirol       Date:  2014-01-24       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.